null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Reframing Pharma through Global Health and Social Science (Evidence Ecologies)

List Price: $73.99
SKU:
9781041326007
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Gregory Patrick Fagan
    Format:
    Hardcover
    Pages:
    186
    Publisher:
    CRC Press (April 24, 2026)
    Imprint:
    CRC Press
    Release Date:
    April 24, 2026
    Language:
    English
    Audience:
    General/trade
    ISBN-13:
    9781041326007
    Weight:
    17.75oz
    Dimensions:
    5.4375" x 8.5"
    File:
    TAYLORFRANCIS-TayFran_260423043234077-20260423.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $73.99
    Country of Origin:
    United States
    Pub Discount:
    30
    Series:
    Global Science Education
    As low as:
    $70.29
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
  • Overview

    This book explores how pharmaceutical evidence is designed, interpreted, and used. It shows how dominant evidence paradigms often struggle to account for time, population heterogeneity, patient experience, and context across contemporary therapeutic and care settings, and advances an evidence ecology approach.